Cargando…
Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
Endothelin is a chemical mediator that helps in maintaining balance within the blood-brain barrier by regulating the levels of toxicants and molecules which pass through the brain, suggesting that a rise in its production determines Alzheimer's disease. The inequity in the amyloid β occurs due...
Autores principales: | Sharma, Shiwali, Behl, Tapan, Kumar, Anoop, Sehgal, Aayush, Singh, Sukhbir, Sharma, Neelam, Bhatia, Saurabh, Al-Harrasi, Ahmed, Bungau, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440097/ https://www.ncbi.nlm.nih.gov/pubmed/34532504 http://dx.doi.org/10.1155/2021/7396580 |
Ejemplares similares
-
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
por: Behl, Tapan, et al.
Publicado: (2022) -
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
por: Behl, Tapan, et al.
Publicado: (2021) -
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022) -
Exploring the role of cathepsin in rheumatoid arthritis
por: Behl, Tapan, et al.
Publicado: (2022) -
Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D
por: Behl, Tapan, et al.
Publicado: (2021)